Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2005. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the 
                        **Federal Register**
                        . This publication implements the IOM's recommendation.
 FOR FURTHER INFORMATION CONTACT: Theresa L. Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.


SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the 
                    **Federal Register**
                    ; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the 
                    **Federal Register**
                    . However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at 
                    *http://www.fda.gov/​oc/​advisory/​default.htm*. FDA will continue to publish a 
                    **Federal Register**
                     notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20). The following list announces FDA's tentatively scheduled advisory committee meetings for 2005. You may also obtain up-to-date meeting information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). Committee Name
Tentative Date(s) of Meetings
Advisory Committee 10-Digit Information Line CodeOFFICE OF THE COMMISSIONERPediatric Advisory Committee
February 14-15, June-day to be announced, November-day to be announced
8732310001Science Board to the Food and Drug Administration
April 15, November-day to be announced
3014512603CENTER FOR BIOLOGICS EVALUATION AND RESEARCHAllergenic Products Advisory Committee
April 7
3014512388Cellular, Tissue and Gene Therapies Advisory Committee (formerly Biological Response Modifiers Advisory Committee)
March 3-4, July 28-29, November 9-10
3014512389Blood Products Advisory Committee
March 17-18, July 21-22, December 1-2
3014519516Transmissible Spongiform Encephalopathies Advisory Committee
February 8-9, June 28-29, October 27-28
3014512392Vaccines and Related Biological Products Advisory Committee
February 16-17, March 15-16, May 4-5, September 20-21, November 16-17
3014512391CENTER FOR DRUG EVALUATION AND RESEARCHAnesthetic and Life Support Drugs Advisory Committee
May 24-25, July 20-21, November 9-10
3014512529Anti-Infective Drugs Advisory Committee
To Be Announced
3014512530Antiviral Drugs Advisory Committee
March 10-11, August 3-4
3014512531Arthritis Advisory Committee
February 16-17, May 12-13, September 15-16
3014512532( print page 75986)Cardiovascular and Renal Drugs Advisory Committee
February 24, April 5-6, June 15-16, August 17-18, November 16-17
3014512533Dermatologic and Ophthalmic Drugs Advisory Committee
March 24-25—Joint Meeting with Nonprescription Drugs Advisory Committee, June 2-3, October 20-21, November 3-4
3014512534Drug Safety and Risk Management Advisory Committee
March 8-9—Joint Meeting with Gastrointestinal Drugs Advisory Committee, June 2-3, October 20-21, November 3-4
3014512535Endocrinologic & Metabolic Drugs Advisory Committee
January 13-14—Joint Meeting with Nonprescription Drugs Advisory Committee, May 5-6, September 22-23, December 13-14
3014512536Gastrointestinal Drugs Advisory Committee
March 9—Joint Meeting with Drug Safety and Risk Management Advisory Committee, March 10, October-day to be announced
3014512538Nonprescription Drugs Advisory Committee
January 13-14-Joint Meeting with Endocrinologic and Metabolic Drugs Advisory Committee 
                             March 23-25—Joint Meeting with Dermatologic and Ophthalmic Drugs Advisory Committee
3014512541Oncologic Drugs Advisory Committee
March 2-3, May 11-12, September 13-14, December 7-8
3014512542Peripheral and Central Nervous System Drugs
May 4
3014512543Pharmaceutical Science, Advisory Committee for (Parent Committee)
April, October—Parent Committee-days to be announced 
                             April, November—Clinical Pharmacology Subcommittee-days to be announced 
                              
                             March, June, September—Manufacturing Subcommittee-days to be announced
3014512539Psychopharmacologic Drugs Advisory Committee
To be announced
3014512544Pulmonary-Allergy Drugs Advisory Committee
April 27-28, August 30-31, December 12-13
3014512545Reproductive Health Drugs, Advisory Committee for
To be announced
3014512537CENTER FOR DEVICES AND RADIOLOGICAL HEALTHDevice Good Manufacturing Practice Advisory Committee
December-day to be announced
3014512398Medical Devices Advisory Committee (Comprised of 18 Panels)Anesthesiology and Respiratory Therapy Devices Panel
April 25-26, November 3-4
3014512624Circulatory System Devices Panel
January 13, March 17, May 19, July 21, September 22, November 17
3014512625Clinical Chemistry and Clinical Toxicology Devices Panel
March 21-22, April 21-22, May 23-24, July 11-12, September 8-9, December 5-6
3014512514Dental Products Panel
April 11-12, July 18-19
3014512518Ear, Nose, and Throat Devices Panel
February 24-25, April 28-29, June 20-21, August 1-2, October 6-7, December 1-2
3014512522Gastroenterology-Urology Devices Panel
March 4, May 3, July 22, October 21
3014512523General and Plastic Surgery Devices Panel
February 7-8, June 9-10, August 25-26, November 7-8
3014512519General Hospital and Personal Use Devices Panel
February 10-11, May 9-10, August 8-9, December 5-6
3014512520Hematology and Pathology Devices Panel
April 29, October 21
3014512515Immunology Devices Panel
May 19, November 10
3014512516( print page 75987)Medical Devices Dispute Resolution Panel
Meeting(s) scheduled as needed
3014510232Microbiology Devices Panel
March 31-April 1, June 16-17, September 19-20, December 8-9
3014512517Molecular and Clinical Genetics Panel
April 18-19, October 17-18
3014510231Neurological Devices Panel
April 28-29, June 20-21, September 22-23, December 1-2
3014512513Obstetrics and Gynecology Devices Panel
March 10-11, May 16-17, August 15-16, November 14-15
3014512524Ophthalmic Devices Panel
March 17-18, May 12-13, July 28-29, September 29-30, November 17-18
3014512396Orthopaedic and Rehabilitation Devices Panel
January 31-February 1, April 7-8, July 25-26, November 3- 4
3014512521Radiological Devices Panel
February 1, May 10, August 2, November 1
3014512526National Mammography Quality Assurance Advisory Committee
April 18
3014512397Technical Electronic Product Radiation Safety Standards Committee
May 18
3014512399CENTER FOR FOOD SAFETY AND APPLIED NUTRITIONFood Advisory Committee—Parent
July-day to be announced
3014510564Additives and Ingredients Subcommittee
June-day to be announced
Do.Biotechnology Subcommittee
July-day to be announced
Do.Contaminants and Natural Toxicants Subcommittee
November-day to be announced
Do.Dietary Supplements Subcommittee
To be announced
Do.Infant Formula Subcommittee
August-day to be announced
Do.Nutrition Subcommittee
To be announced
Do.CENTER FOR VETERINARY MEDICINEVeterinary Medicine Advisory Committee
January 31, May 19, October 20
3014512548NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR)Science Advisory Board to NCTR
March 30-31
3014512559Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants
May, September, November-days to be announced
3014512560
 Dated: December 8, 2004. Sheila Dearybury Walcoff, Associate Commissioner for External Relations.


[FR Doc. 04-27737 Filed 12-17-04; 8:45 am] BILLING CODE 4160-01-S